VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling

Nature Cell Biology

Volumn 13, Issue 10, 2011, Pages 1202-1213

  Tammela, Tuomas ^a,b   Zarkada, Georgia ^a   Nurmi, Harri ^a   Jakobsson, Lars ^b,i   Heinolainen, Krista ^a   Tvorogov, Denis ^a   Zheng, Wei ^a   Franco, Claudio A ^b   Murtomäki, Aino ^a   Aranda, Evelyn ^c   Miura, Naoyuki ^d   Ylä Herttuala, Seppo ^e   Fruttiger, Marcus ^f   Mäkinen, Taija ^a,i   Eichmann, Anne ^g   Pollard, Jeffrey W ^c   Gerhardt, Holger ^b,h   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g INSERM   (France)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE DELETION; HETEROZYGOSITY; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN KINASE INHIBITORS; RECEPTORS, NOTCH; RETINAL VESSELS; RHOMBENCEPHALON; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

MUS;

EID: 80053564674     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2331     Document Type: Article

References (71)

1. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 438-442 (1996).
2. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996). (Pubitemid 26102719)
3. Shalaby, F. et al. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
4. Gille, H. et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 276, 3222-3230 (2001).
5. Tammela, T. & Alitalo, K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140, 460-476 (2010).
6. Dixelius, J. et al. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J. Biol. Chem. 278, 40973-40979 (2003). (Pubitemid 37280919)
7. Nilsson, I. et al. VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29, 1377-1388 (2010).
8. Dumont, D. J. et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949 (1998). (Pubitemid 28507528)
9. Covassin, L. D., Villefranc, J. A., Kacergis, M. C., Weinstein, B. M. & Lawson, N. D. Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebra fish. Proc. Natl Acad. Sci. USA 103, 6554-6559 (2006).
10. Kaipainen, A. et al. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl Acad. Sci. USA 92, 3566-3570 (1995).
11. Lohela, M., Helotera, H., Haiko, P., Dumont, D. J. & Alitalo, K. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am. J. Pathol. 173, 1891-1901 (2008).
12. Paavonen, K., Puolakkainen, P., Jussila, L., Jahkola, T. & Alitalo, K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156, 1499-1504 (2000). (Pubitemid 30646689)
13. Valtola, R. et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154, 1381-1390 (1999). (Pubitemid 29226433)
14. Tammela, T. et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656-660 (2008).
15. Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74-80 (2004). (Pubitemid 38081471)
16. Baldwin, M. E. et al. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell Biol. 25, 2441-2449 (2005). (Pubitemid 40354637)
17. Haiko, P. et al. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol. Cell Biol. 28, 4843-4850 (2008).
18. Gerhardt, H. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cellfilopodia. J. Cell Biol. 161, 1163-1177 (2003). (Pubitemid 36870177)
19. Hellstrom, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780 (2007). (Pubitemid 46279716)
20. Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl Acad. Sci. USA 104, 3225-3230 (2007). (Pubitemid 46364141)
21. Roca, C. & Adams, R. H. Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 21, 2511-2524 (2007). (Pubitemid 47607663)
22. Kamei, M. et al. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 442, 453-456 (2006). (Pubitemid 44264794)
23. Strilic, B. et al. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev. Cell 17, 505-515 (2009).
24. Fantin, A. et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116, 829-840 (2010).
25. Kubota, Y. et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J. Exp. Med. 206, 1089-1102 (2009).
26. Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010).
27. Siekmann, A. F. & Lawson, N. D. Notch signalling limits angiogenic cell behaviour in developing zebra fish arteries. Nature 445, 781-784 (2007). (Pubitemid 46279717)
28. Benedito, R. et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124-1135 (2009).
29. Claxton, S. et al. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46, 74-80 (2008). (Pubitemid 351498176)
30. Le Bras, B. et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 9, 340-348 (2006). (Pubitemid 43290963)
31. Skobe, M. et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159, 893-903 (2001). (Pubitemid 32847180)
32. Karkkainen, M. J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl Acad. Sci. USA 98, 12677-12682 (2001). (Pubitemid 33020005)
33. Galvagni, F. et al. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ. Res. 106, 1839-1848 (2010).
34. Jakobsson, L. et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 12, 943-953 (2010).
35. Wiktor-Jedrzejczak, W. W., Ahmed, A., Szczylik, C. & Skelly, R. R. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156, 1516-1527 (1982). (Pubitemid 13232211)
36. Takeshita, K. et al. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ. Res. 100, 70-78 (2007). (Pubitemid 46066775)
37. Yamamizu, K. et al. Convergence of Notch andβ-catenin signaling induces arterial fate in vascular progenitors. J. Cell Biol. 189, 325-338 (2010).
38. Hayashi, H. & Kume, T. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 3, e2401 (2008).
39. Burgering, B. M. A brief introduction to FOXOlogy. Oncogene 27, 2258-2262 (2008). (Pubitemid 351501787)
40. Petrova, T. V. et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10, 974-981 (2004). (Pubitemid 39273739)
41. Norrmen, C. et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185, 439-457 (2009).
42. Laakkonen, P. et al. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res. 67, 593-599 (2007). (Pubitemid 46192197)
43. Davis, G. E. & Senger, D. R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97, 1093-1107 (2005).
44. Zhang, L. et al. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 20, 1319-1331 (2010).
45. Nilsson, I. et al. VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29, 1377-1388 (2010).
46. Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483-486 (2010).
47. Sawamiphak, S. et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465, 487-491 (2010).
48. Saharinen, P. et al. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev. 24, 875-880 (2010).
49. Whitaker, G. B., Limberg, B. J. & Rosenbaum, J. S. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J. Biol. Chem. 276, 25520-25531 (2001).
50. Carmeliet, P. et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147-157 (1999). (Pubitemid 29344903)
51. Shawber, C. J. et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J. Clin. Invest. 117, 3369-3382 (2007). (Pubitemid 350096993)
52. Ober, E. A. et al. Vegfc is required for vascular development and endoderm morphogenesis in zebra fish. EMBO Rep. 5, 78-84 (2004). (Pubitemid 38228532)
53. De Palma, M., Venneri, M. A., Roca, C. & Naldini, L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modi-ed hematopoietic stem cells. Nat. Med. 9, 789-795 (2003). (Pubitemid 36749231)
54. Mäkinen, T. et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C receptor VEGFR-3. EMBO J. 20, 4762-4773 (2001). (Pubitemid 32848629)
55. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999). (Pubitemid 29036285)
56. Iida, K. et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124, 4627-4638 (1997). (Pubitemid 27519257)
57. Pytowski, B. et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J. Natl Cancer Inst. 97, 14-21 (2005).
58. Prewett, M. et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 59, 5209-5218 (1999). (Pubitemid 29503984)
59. Weijzen, S. et al. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J. Immunol. 169, 4273-4278 (2002). (Pubitemid 35178199)
60. Tammela, T. et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105, 4642-4648 (2005). (Pubitemid 40807283)
61. Baluk, P. et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115, 247-257 (2005). (Pubitemid 40385467)
62. Ruhrberg, C. et al. Spatially restricted patterning cues provided by heparinbinding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16, 2684-2698 (2002).
63. Karpanen, T. et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol. 169, 708-718 (2006). (Pubitemid 44156326)
64. Zheng, W. et al. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood 118, 1154-1162 (2011).
65. Tvorogov, D. et al. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell 18, 630-640 (2010).
66. Jussila, L. et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58, 1599-1604 (1998). (Pubitemid 28215077)
67. Ghalamkarpour, A. et al. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J. Med. Genet. 46, 399-404 (2009).
68. Persaud, K. et al. Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C. J. Cell Sci. 117, 2745-2756 (2004). (Pubitemid 38997257)
69. Karpanen, T. et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472 (2006). (Pubitemid 44943854)
70. Jakobsson, L. et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 10, 625-634 (2006).
71. Lobov, I. B. et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl Acad. Sci. USA 104, 3219-3224 (2007). (Pubitemid 46364140)